Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration
Closed Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2DP-25-R-0001
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is seeking to procure Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration (Adeno) through solicitation SPE2DP-25-R-0001. The vaccine will consist of live, enteric-coated tablets suitable for oral administration, packaged in sets of two bottles containing 100 tablets each of Type 4 and Type 7 vaccines. Key contract requirements include FDA approval to supply the vaccine before award and the ability to deliver to military recruiting activities throughout the United States. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS), with interested parties advised to register for automated notifications. The pre-solicitation notice indicates the solicitation is expected to be issued around August 2025, with a proposal response deadline of June 25, 2025.
The contract will be a firm-fixed price, indefinite delivery, indefinite quantity type with one base year and four one-year option periods. The estimated annual quantity is 2,000 package groups (PG), with a minimum of 1,500 PG and a maximum of 2,300 PG per year. There are no specific set-aside designations for this opportunity, meaning all responsible sources may submit proposals. Delivery is scheduled on a monthly basis, with first deliveries expected to begin three months after contract award. The procurement falls under the Pharmaceutical Preparation Manufacturing NAICS category (325412) and the Drugs and Biologicals PSC category (6505). The government will use authority 10 U.S.C. 2304(c)(1) for this acquisition and does not intend to use Part 12 procurement procedures.
Notice text
Solicitation: SPE2DP-25-R-0001
Item: Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration (Adeno)
NSN: 6505-01-642-0106
Description(s):
The Defense Logistics Agency Troop Support has a requirement for the supply of Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration (Adeno). NSN 6505-01-642-0106. The vaccine shall be enteric-coated tablets of live, adenovirus Type 4 and Type 7 suitable for oral administration only. One Package (PG) consists of Two (2) bottles of 100 tablets each of Type 4 and 100 tablets each of Type 7 Adenovirus Vaccine, Live, Oral. Other specification data will be included in the solicitation.
The Solicitation will be issued under authority 10 U.S.C. 2304(c)(1).
The Government does not intend to use Part 12 for this acquisition – per FAR 10.002(d)(2).
The successful contractor shall have FDA approval to supply Adeno before award decision.
The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of one (1) base year and four (4) one-year options. The estimated annual quantity for the base year and each option year is 2,000 PG. There will be a minimum quantity of 1,500 PG and a maximum quantity of 2,300 PG for the base year and each option year. (Quantities may increase or decrease pending receipt of final Service requirements.)
FOB Destination. Ordered quantities shall be delivered to military recruiting activities located throughout the United States. Delivery is scheduled on a monthly basis. First deliveries shall begin 3 months after award of contract, or best available delivery, negotiated between the contractor and the Government.
All responsible sources may submit a proposal, which, if timely received, shall be considered by the Agency.
****************************************************************************
IMPORTANT NOTICES
Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-25-R-0001 is expected to be issued on or around August 2025.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration | Solicitation | |
| This notice | Pre-Solicitation | |
| Adenovirus Type 4 and Type 7 Vaccine, Live, Oral, Enteric Coated Tablets for Oral Administration | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Atropine Auto-Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity